Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Regulators in the EU, UK, and US already mandate the structured capture of medical device safety data. Now they are beginning to analyze it, and they expect device manufacturers to be doing the same. Existing capabilities, however, may hold companies back, warns Qinecsa’s Jonathan Messer.
A Southern California start-up uses a blood test-based method to address glaring gaps in ovarian cancer diagnosis.
The treatment of low back pain is beginning to move toward a more stratified, personalized model of care. Scientific and technological advances are creating opportunities for new entrants in the market. Excerpted from our recent feature article.